The Evolving Pharma M&A Landscape

Emerging Trends and Predicted Post-Blockbuster Targets

Product Code RBI00325
Publication Date September 2009
Publisher Business Insights
Product Type Report
Pages 242
Buy this product or for assistance call +44 20 7060 7474

Pharmaceutical industry growth rates have halved since 2003, and fell below 5% in 2008. The sector is under unprecedented pressure ??

  • Executive Summary
    • Pharmaceutical industry pressure points
    • Can mega-mergers solve the industry's problems?
    • Big pharma M&A
    • Generic industry M&A
    • Biotech industry M&A
  • Chapter 1 Pharmaceutical industry pressure points
    • Summary
    • Introduction
    • Diminishing returns
    • Stock market reaction
    • Key factors behind the squeeze on big pharma
    • Patent expiries
    • Pharmaceutical cost-containment
    • Deteriorating R&D risk/return ratios
    • Adapting to the new market environment
    • Cost-cutting and efficiency increases
    • Enhancing pipelines
    • Corporate restructuring
  • Chapter 2 Can mega-mergers solve the industry's problems?
    • Summary
    • Introduction
    • The last wave of mega-mergers
    • Mega-merger legacies
    • Pfizer ??

Delivery Details

PDF:Delivered by email usually within 4 to 8 UK business hours.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment